The collaboration provides VedaBio access to essential CRISPR IP, accelerating the development of customised diagnostic ...
Schematic illustration of nucleic acid detection by the conventional CRISPR assay and the asymmetric CRISPR assay. Credit: Nature Communications (2023). DOI: 10.1038/s41467-023-43389-7 Changchun Liu, ...
Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing ...
VedaBio, a pioneering biotechnology company transforming molecular detection, today announced a non-exclusive license agreement with Mammoth Biosciences, Inc. for the use of select CRISPR-based ...
Originally developed for gene editing, CRISPR-Cas systems have now become powerful molecular diagnostic tools. However, their widespread adoption in diagnostics has relied heavily on traditional ...
Genetic editing holds promise to treat incurable diseases, but the most popular method—CRISPR—sometimes does more harm than ...
Coronavirus Disease 2019 (COVID-19) has driven the use of nucleic acid testing technology in clinical testing. There is a growing need for point-of-care testing (POCT) devices that can integrate ...
Tulane University researchers have developed an enhanced CRISPR-based tuberculosis test that works with a simple tongue swab, ...
The COVID pandemic was a make or break moment for many a biotech. At Mammoth Biosciences, it may have been a little of both. For Janice Chen, Ph.D., the CRISPR biotech's chief technology officer and ...
20hon MSN
Genetically engineered mice could take the bite out of Lyme disease on Nantucket, scientists say
Scientists hope genetically modified mice will curb the spread of Lyme disease. They headed to Nantucket — home to a large ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback